Compare JCI & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JCI | COR |
|---|---|---|
| Founded | 1885 | 2001 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.0B | 68.5B |
| IPO Year | 2007 | 2001 |
| Metric | JCI | COR |
|---|---|---|
| Price | $132.82 | $334.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $133.31 | ★ $395.23 |
| AVG Volume (30 Days) | ★ 3.4M | 833.5K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.23% | 0.69% |
| EPS Growth | ★ 99.60 | 5.71 |
| EPS | 0.85 | ★ 2.87 |
| Revenue | $9,902,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $7.66 | $8.97 |
| Revenue Next Year | $6.44 | $6.76 |
| P/E Ratio | $153.70 | ★ $117.68 |
| Revenue Growth | N/A | ★ 9.31 |
| 52 Week Low | $68.03 | $262.73 |
| 52 Week High | $146.49 | $377.54 |
| Indicator | JCI | COR |
|---|---|---|
| Relative Strength Index (RSI) | 46.68 | 32.84 |
| Support Level | $111.18 | $331.73 |
| Resistance Level | $146.49 | $353.18 |
| Average True Range (ATR) | 3.21 | 8.02 |
| MACD | -1.68 | -3.35 |
| Stochastic Oscillator | 21.57 | 11.41 |
Following Johnson Controls' divestiture of its residential and light commercial HVAC businesses to Bosch in 2025, nearly all of its revenue comes from commercial HVAC (60%) and fire and security products and services (40%). A 2016 merger joined Johnson Controls' HVAC and Tyco's fire and security businesses with the premise that there is synergy in offering a broader variety of automation products and solutions to commercial buildings. We estimate Johnson Controls' pro forma revenue mix will be one-third products, one-third installation, and one-third services.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.